• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估多种硝基芳香前药代谢物从革兰氏阴性细菌模型载体中排出能力的方案。

Protocol for evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative bacterial vector.

作者信息

Chan-Hyams Jasmine V E, Ackerley David F

机构信息

School of Biological Sciences, Victoria University of Wellington, Wellington, 6012, New Zealand.

Centre for Biodiscovery, Victoria University of Wellington, Wellington, 6012, New Zealand.

出版信息

MethodsX. 2020 Jan 23;7:100797. doi: 10.1016/j.mex.2020.100797. eCollection 2020.

DOI:10.1016/j.mex.2020.100797
PMID:32021829
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6995258/
Abstract

Bacterial-directed enzyme-prodrug therapy (BDEPT) uses tumour-tropic bacteria armed with a genetically-encoded prodrug-converting enzyme to sensitise tumours to a systemically-administered prodrug. A strong bystander effect (i.e., efficient bacteria-to-tumour transfer of activated prodrug metabolites) is critical to maximise tumour cell killing and avoid bacterial self-sterilisation. To investigate the bystander effect in bacteria we developed a sensitive screen that utilised two strains grown in co-culture. The first of these was an activator strain that overexpressed the nitroreductase NfsA, and the second was a nitroreductase null recipient strain bearing an SOS-GFP DNA damage responsive gene construct. In this system, induction of GFP by genotoxic prodrug metabolites can only occur following their transfer from the activator to the recipient cells. This can be monitored both in fluorescence based microtitre plate assays and by flow-cytometry, enabling modelling of the abilities of diverse nitroaromatic prodrug metabolites to exit a Gram negative vector.

摘要

细菌导向酶-前药疗法(BDEPT)利用携带基因编码前药转化酶的肿瘤靶向细菌,使肿瘤对全身给药的前药敏感。强大的旁观者效应(即活化的前药代谢物从细菌到肿瘤的有效转移)对于最大限度地杀伤肿瘤细胞和避免细菌自我杀菌至关重要。为了研究细菌中的旁观者效应,我们开发了一种灵敏的筛选方法,该方法利用共培养的两种菌株。其中第一种是过表达硝基还原酶NfsA的激活菌株,第二种是携带SOS-GFP DNA损伤响应基因构建体的硝基还原酶缺失受体菌株。在这个系统中,遗传毒性前药代谢物诱导GFP表达只能在它们从激活菌株转移到受体细胞后发生。这可以在基于荧光的微量滴定板分析和流式细胞术中进行监测,从而能够模拟不同硝基芳香族前药代谢物从革兰氏阴性载体中释放出来的能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b937/6995258/b8b2fabc8d61/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b937/6995258/01873e333ac4/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b937/6995258/21234943f6e2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b937/6995258/b8b2fabc8d61/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b937/6995258/01873e333ac4/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b937/6995258/21234943f6e2/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b937/6995258/b8b2fabc8d61/gr2.jpg

相似文献

1
Protocol for evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative bacterial vector.评估多种硝基芳香前药代谢物从革兰氏阴性细菌模型载体中排出能力的方案。
MethodsX. 2020 Jan 23;7:100797. doi: 10.1016/j.mex.2020.100797. eCollection 2020.
2
Evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative vector for bacterial-directed enzyme-prodrug therapy.评估不同硝基芳香族前药代谢物离开革兰氏阴性模型载体的能力,用于细菌定向酶前药治疗。
Biochem Pharmacol. 2018 Dec;158:192-200. doi: 10.1016/j.bcp.2018.10.020. Epub 2018 Oct 21.
3
Engineering the Nitroreductase NfsA to Create a Flexible Enzyme-Prodrug Activation System.工程改造硝基还原酶NfsA以创建一个灵活的酶-前药激活系统。
Front Pharmacol. 2021 Jun 7;12:701456. doi: 10.3389/fphar.2021.701456. eCollection 2021.
4
Discovery and evaluation of Escherichia coli nitroreductases that activate the anti-cancer prodrug CB1954.发现并评估能够激活抗癌前药 CB1954 的大肠杆菌硝基还原酶。
Biochem Pharmacol. 2010 Mar 1;79(5):678-87. doi: 10.1016/j.bcp.2009.10.008. Epub 2009 Oct 21.
5
Creation and screening of a multi-family bacterial oxidoreductase library to discover novel nitroreductases that efficiently activate the bioreductive prodrugs CB1954 and PR-104A.创建并筛选多家族细菌氧化还原酶文库,以发现能有效激活生物还原前药 CB1954 和 PR-104A 的新型硝基还原酶。
Biochem Pharmacol. 2013 Apr 15;85(8):1091-103. doi: 10.1016/j.bcp.2013.01.029. Epub 2013 Feb 8.
6
The bystander effect of the nitroreductase/CB1954 enzyme/prodrug system is due to a cell-permeable metabolite.硝基还原酶/CB1954酶/前药系统的旁观者效应是由一种可透过细胞的代谢物引起的。
Hum Gene Ther. 1997 Apr 10;8(6):709-17. doi: 10.1089/hum.1997.8.6-709.
7
The Flavin Reductase MsuE Is a Novel Nitroreductase that Can Efficiently Activate Two Promising Next-Generation Prodrugs for Gene-Directed Enzyme Prodrug Therapy.黄素还原酶 MsuE 是一种新型的硝基还原酶,可有效地激活两种有前途的用于基因导向酶前药治疗的下一代前药。
Cancers (Basel). 2013 Aug 8;5(3):985-97. doi: 10.3390/cancers5030985.
8
Pseudomonas aeruginosa NfsB and nitro-CBI-DEI--a promising enzyme/prodrug combination for gene directed enzyme prodrug therapy.铜绿假单胞菌 NfsB 和硝基-CBI-DEI——用于基因导向酶前药治疗的有前途的酶/前药组合。
Mol Cancer. 2013 Jun 10;12:58. doi: 10.1186/1476-4598-12-58.
9
Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utility.硝基还原酶基因导向的酶前药疗法:临床应用的见解与进展
Biochem J. 2015 Oct 15;471(2):131-53. doi: 10.1042/BJ20150650.
10
Sensitisation of human carcinoma cells to the prodrug CB1954 by adenovirus vector-mediated expression of E. coli nitroreductase.通过腺病毒载体介导的大肠杆菌硝基还原酶表达使人类癌细胞对前药CB1954致敏。
Int J Cancer. 2000 Jun 15;86(6):848-54. doi: 10.1002/(sici)1097-0215(20000615)86:6<848::aid-ijc14>3.0.co;2-b.

引用本文的文献

1
Bacteria-Mediated Synergistic Cancer Therapy: Small Microbiome Has a Big Hope.细菌介导的协同癌症治疗:微小的微生物群带来巨大希望。
Nanomicro Lett. 2021 Jan 4;13(1):37. doi: 10.1007/s40820-020-00560-9.

本文引用的文献

1
Evaluating the abilities of diverse nitroaromatic prodrug metabolites to exit a model Gram negative vector for bacterial-directed enzyme-prodrug therapy.评估不同硝基芳香族前药代谢物离开革兰氏阴性模型载体的能力,用于细菌定向酶前药治疗。
Biochem Pharmacol. 2018 Dec;158:192-200. doi: 10.1016/j.bcp.2018.10.020. Epub 2018 Oct 21.
2
Engineering a Multifunctional Nitroreductase for Improved Activation of Prodrugs and PET Probes for Cancer Gene Therapy.工程化一种多功能硝基还原酶以改善前药和用于癌症基因治疗的正电子发射断层显像(PET)探针的激活。
Cell Chem Biol. 2017 Mar 16;24(3):391-403. doi: 10.1016/j.chembiol.2017.02.005. Epub 2017 Mar 2.
3
Reduction of quinones and nitroaromatic compounds by Escherichia coli nitroreductase A (NfsA): Characterization of kinetics and substrate specificity.
大肠杆菌硝基还原酶A(NfsA)对醌类和硝基芳香族化合物的还原作用:动力学和底物特异性表征
Arch Biochem Biophys. 2017 Jan 15;614:14-22. doi: 10.1016/j.abb.2016.12.005. Epub 2016 Dec 13.
4
Nitroreductase gene-directed enzyme prodrug therapy: insights and advances toward clinical utility.硝基还原酶基因导向的酶前药疗法:临床应用的见解与进展
Biochem J. 2015 Oct 15;471(2):131-53. doi: 10.1042/BJ20150650.
5
Toward a high-throughput screening platform for directed evolution of enzymes that activate genotoxic prodrugs.构建用于激活基因毒性前药的酶定向进化的高通量筛选平台。
Protein Eng Des Sel. 2014 Oct;27(10):399-403. doi: 10.1093/protein/gzu025. Epub 2014 Jul 4.
6
Creation and screening of a multi-family bacterial oxidoreductase library to discover novel nitroreductases that efficiently activate the bioreductive prodrugs CB1954 and PR-104A.创建并筛选多家族细菌氧化还原酶文库,以发现能有效激活生物还原前药 CB1954 和 PR-104A 的新型硝基还原酶。
Biochem Pharmacol. 2013 Apr 15;85(8):1091-103. doi: 10.1016/j.bcp.2013.01.029. Epub 2013 Feb 8.
7
Discovery and evaluation of Escherichia coli nitroreductases that activate the anti-cancer prodrug CB1954.发现并评估能够激活抗癌前药 CB1954 的大肠杆菌硝基还原酶。
Biochem Pharmacol. 2010 Mar 1;79(5):678-87. doi: 10.1016/j.bcp.2009.10.008. Epub 2009 Oct 21.
8
Quantitation of bystander effects in nitroreductase suicide gene therapy using three-dimensional cell cultures.使用三维细胞培养对硝基还原酶自杀基因疗法中的旁观者效应进行定量分析。
Cancer Res. 2002 Mar 1;62(5):1425-32.